INCREASED SURVIVAL IN PATIENTS WITH HEPATIC ENCEPHALOPATHY TREATED WITH RIFAXIMIN-ALPHA IN COMBINATION WITH LACTULOSE: AN OBSERVATIONAL STUDY IN 4669 PATIENTS FROM UK CLINICAL PRACTICE

Bharat Amlani  ¹     Sean Walsh    
¹ Norgine Ltd, Harefield, United Kingdom

Topic
Digestive Oncology, Hepatobiliary

Session
Advances in cirrhosis

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)